Small studies published in JAMA suggest that Fluvoxamine, a common antidepressant used for OCD, may prevent severe COVID-19 symptoms. The hosts suggest this supports their theory that the pandemic involves a significant element of mass hysteria.
2 chapters across the catalog
Small studies published in JAMA suggest that Fluvoxamine, a common antidepressant used for OCD, may prevent severe COVID-19 symptoms. The hosts suggest this supports their theory that the pandemic involves a significant element of mass hysteria.
GW Pharma, Sativex and the Medical Marijuana Transition
GW Pharmaceuticals is bringing Sativex, a liquid cannabinoid medicine, to market. The discussion suggests that the current crackdown on independent medical marijuana dispensaries is a coordinated effort to transition the industry into the hands of approved pharmaceutical dealers. This shift is viewed as a financial strategy to benefit corporate interests and political donors.